Stifel Nicolaus Downgrades Colgate-Palmolive (NYSE:CL) to Hold

Colgate-Palmolive (NYSE:CL) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a report released on Monday, MarketBeat Ratings reports. They presently have a $101.00 price objective on the stock, down from their previous price objective of $105.00. Stifel Nicolaus’ price objective would indicate a potential upside of 6.60% from the stock’s current price.

Several other analysts also recently issued reports on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price target for the company from $107.00 to $109.00 in a research report on Monday, September 9th. Bank of America lifted their price target on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. UBS Group lifted their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Morgan Stanley lifted their price target on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. Finally, Evercore ISI lifted their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research report on Thursday, July 18th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $105.11.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $94.75 on Monday. The company has a market cap of $77.74 billion, a price-to-earnings ratio of 29.98, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40. Colgate-Palmolive has a 52 week low of $72.36 and a 52 week high of $109.30. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. The firm has a 50 day moving average of $102.86 and a 200-day moving average of $98.19.

Insider Transactions at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $102.94, for a total value of $1,522,894.36. Following the sale, the insider now directly owns 5,146 shares in the company, valued at approximately $529,729.24. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock worth $4,486,063 in the last ninety days. Company insiders own 0.34% of the company’s stock.

Institutional Investors Weigh In On Colgate-Palmolive

Several hedge funds and other institutional investors have recently modified their holdings of CL. Aviance Capital Partners LLC increased its position in shares of Colgate-Palmolive by 43.1% during the first quarter. Aviance Capital Partners LLC now owns 3,650 shares of the company’s stock valued at $329,000 after buying an additional 1,100 shares during the period. Hexagon Capital Partners LLC increased its position in shares of Colgate-Palmolive by 49.6% during the first quarter. Hexagon Capital Partners LLC now owns 1,164 shares of the company’s stock valued at $105,000 after buying an additional 386 shares during the period. Allspring Global Investments Holdings LLC increased its position in shares of Colgate-Palmolive by 461.5% during the first quarter. Allspring Global Investments Holdings LLC now owns 1,036,215 shares of the company’s stock valued at $93,311,000 after buying an additional 851,671 shares during the period. Farmers & Merchants Investments Inc. increased its position in shares of Colgate-Palmolive by 1.2% during the first quarter. Farmers & Merchants Investments Inc. now owns 36,381 shares of the company’s stock valued at $3,276,000 after buying an additional 431 shares during the period. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new stake in shares of Colgate-Palmolive during the first quarter valued at about $1,467,000. 80.41% of the stock is currently owned by institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.